npj Breast Cancer, 2374-4677

Tidskrift

Fler filtreringsmöjligheter
  1. 2020
  2. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

    Jan Hudeček, Hugo M Horlings, International Immuno-Oncology Biomarker Working Group International Immuno-Oncology Biomarker Working Group & Anna Ehinger, 2020 dec 1, I : npj Breast Cancer. 6, 1, 15.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  3. Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

    Zuzana Kos, Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen, Koen K. van de Vijver, Shom Goel, Sylvia Adams, Sandra Demaria, Giuseppe Viale, Torsten O Nielsen, Sunil S Badve, W. Fraser Symmans, Christos Sotiriou, David L Rimm, Stephen Hewitt, Carsten Denkert, Sibylle Loibl, Anna Ehinger & 1 andra, Roberto Salgado, 2020 maj 12, I : npj Breast Cancer. 6, 17.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

    Mohamed Amgad, Lee A. D. Cooper, International Immuno-Oncology Biomarker Working Group International Immuno-Oncology Biomarker Working Group & Anna Ehinger, 2020 maj 12, I : npj Breast Cancer. 6, 16, 16.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2019
  6. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

    Gisella Figlioli, Hermann Brenner, Carolina Ellberg, Per Hall, Håkan Olsson, Paolo Peterlongo, ABCTB Investigators ABCTB Investigators, GEMO Study Collaborators GEMO Study Collaborators & KConFab Investigators KConFab Investigators, 2019, I : npj Breast Cancer. 5, 1, 38.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift